Is Galera Therapeutics Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Galera Therapeutics Inc (GRTX) is currently classified as NOT HALAL as of July 2024. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Galera Therapeutics Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Galera Therapeutics Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Galera Therapeutics Inc?

Muslim investors may consider investing in Galera Therapeutics Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Galera Therapeutics Inc classified as NOT HALAL?

Musaffa determines the Shariah status of Galera Therapeutics Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Galera Therapeutics Inc updated?

The Shariah compliance status of Galera Therapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Galera Therapeutics Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Galera Therapeutics Inc?

You can check the latest Shariah compliance status of Galera Therapeutics Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

GRTX Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: July 29, 2024

Report Source: 2024 1st Quarter Report

Galera Therapeutics Inc. Stock Analysis GRTX

United States Health Care Nano Cap Report: Q1, 2024

Galera Therapeutics, Inc. is a clinical stage biotechnology company, which engages in developing and commercializing a pipeline of novel, proprietary therapeutics for cancer. The company is headquartered in Malvern, Pennsylvania and currently employs 3 full-time employees. The company went IPO on 2019-11-07. The firm is focused on advancing a pan-NOS inhibitor through clinical development for patients with the hardest-to-treat forms of advanced breast cancer.

Key Statistics of Galera Therapeutics Inc (GRTX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.10$0.11

Today's Open

$0.10

Volume

48.09K

P/E Ratio (TTM)

0.11

52 Week Range

$0.02$0.15

Market Cap

14.85M

Avg. Volume

236.09K

Dividend Yield

Financial Metrics & Statements of Galera Therapeutics Inc (GRTX)

FAQ's for Galera Therapeutics Inc (GRTX)

According to Musaffa’s Shariah screening methodology, Galera Therapeutics Inc (GRTX) is currently classified as NOT HALAL as of July 2024. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.